Eric M. Mishkin

684 total citations
21 papers, 459 citations indexed

About

Eric M. Mishkin is a scholar working on Epidemiology, Immunology and Pharmacology. According to data from OpenAlex, Eric M. Mishkin has authored 21 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Eric M. Mishkin's work include Herpesvirus Infections and Treatments (12 papers), Immunotherapy and Immune Responses (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Eric M. Mishkin is often cited by papers focused on Herpesvirus Infections and Treatments (12 papers), Immunotherapy and Immune Responses (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Eric M. Mishkin collaborates with scholars based in United States, China and Japan. Eric M. Mishkin's co-authors include G. A. Cabral, Sally T. Ishizaka, Peter J. McNerney, Aaron S. Abramovitz, Jerson L. Silva, Laura J. York, Guy A. Cabral, Louis S. Harris, Albert E. Munson and Philip H. Coleman and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and Journal of General Virology.

In The Last Decade

Eric M. Mishkin

20 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Mishkin United States 13 193 188 184 60 51 21 459
Gerald Lancz United States 15 178 0.9× 135 0.7× 264 1.4× 46 0.8× 91 1.8× 38 603
S. Specter United States 15 85 0.4× 180 1.0× 173 0.9× 147 2.5× 86 1.7× 41 499
Raymond Widen United States 15 183 0.9× 101 0.5× 134 0.7× 15 0.3× 97 1.9× 31 610
O Gubbay United Kingdom 8 71 0.4× 82 0.4× 98 0.5× 10 0.2× 61 1.2× 10 393
W. Ponti Italy 13 45 0.2× 148 0.8× 80 0.4× 33 0.6× 142 2.8× 43 458
Adam T. Hagymasi United States 13 88 0.5× 348 1.9× 60 0.3× 13 0.2× 186 3.6× 19 599
Ken Williams United States 4 121 0.6× 183 1.0× 66 0.4× 294 4.9× 49 1.0× 6 556
Dazhuang Shang United Kingdom 9 23 0.1× 62 0.3× 277 1.5× 35 0.6× 184 3.6× 13 716
Yuan‐Chuan Chen United States 13 31 0.2× 57 0.3× 196 1.1× 27 0.5× 241 4.7× 40 565
Amy C. Herring United States 10 229 1.2× 183 1.0× 235 1.3× 4 0.1× 73 1.4× 12 633

Countries citing papers authored by Eric M. Mishkin

Since Specialization
Citations

This map shows the geographic impact of Eric M. Mishkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Mishkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Mishkin more than expected).

Fields of papers citing papers by Eric M. Mishkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Mishkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Mishkin. The network helps show where Eric M. Mishkin may publish in the future.

Co-authorship network of co-authors of Eric M. Mishkin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Mishkin. A scholar is included among the top collaborators of Eric M. Mishkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Mishkin. Eric M. Mishkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Yifan, Louis Poisson, Guzman Sánchez‐Schmitz, et al.. (2010). Assessing the immunopotency of Toll‐like receptor agonists in an in vitro tissue‐engineered immunological model. Immunology. 130(3). 374–387. 32 indexed citations
2.
Ma, Yifan, Santosh Pawar, Guzman Sánchez‐Schmitz, et al.. (2007). In vitro vaccination site: a novel test bed for immunopotentiators (36.30). The Journal of Immunology. 178(1_Supplement). S18–S18. 1 indexed citations
3.
Cooper, David, Michael W. Pride, Min Guo, et al.. (2004). Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4 CTL responses. Vaccine. 23(2). 236–246. 19 indexed citations
4.
Israel, Zimra R., Agegnehu Gettie, Sally T. Ishizaka, et al.. (1999). Combined Systemic and Mucosal Immunization with Microsphere-Encapsulated Inactivated Simian Immunodeficiency Virus Elicits Serum, Vaginal, and Tracheal Antibody Responses in Female Rhesus Macaques. AIDS Research and Human Retroviruses. 15(12). 1121–1136. 13 indexed citations
5.
6.
Spruance, Spotswood L., Thomas G. Evans, Mark B. McKeough, et al.. (1995). Th1Th2-like immunity and resistance to herpes simplex labialis. Antiviral Research. 28(1). 39–55. 36 indexed citations
7.
Ishizaka, Sally T., et al.. (1995). IgG Subtype Is Correlated with Efficiency of Passive Protection and Effector Function of Anti-Herpes Simplex Virus Glycoprotein D Monoclonal Antibodies. The Journal of Infectious Diseases. 172(4). 1108–1111. 48 indexed citations
8.
Landolfi, Victoria, et al.. (1993). Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge. Vaccine. 11(4). 407–414. 26 indexed citations
9.
10.
Ishizaka, Sally T. & Eric M. Mishkin. (1991). Native HSV Glycoprotein D Subunit Vaccine: Analysis of in Vitro T-Cell Activation and Antigen Presentation*. Viral Immunology. 4(3). 187–193. 6 indexed citations
11.
Mishkin, Eric M., John V. Fahey, Yoichiro Kino, et al.. (1991). Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine. 9(3). 147–153. 29 indexed citations
12.
Cabral, G. A. & Eric M. Mishkin. (1989). Delta‐9‐tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. Journal of Toxicology and Environmental Health. 26(2). 175–182. 30 indexed citations
13.
Cabral, Guy A., Peter J. McNerney, & Eric M. Mishkin. (1987). Delta-9-Tetrahydrocannabinol Inhibits the Splenocyte Proliferative Response to Herpes Simplex Virus Type 2. Immunopharmacology and Immunotoxicology. 9(2-3). 361–370. 4 indexed citations
14.
Cabral, Guy A., Peter J. McNerney, & Eric M. Mishkin. (1987). Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells. Archives of Toxicology. 60(6). 438–449. 19 indexed citations
15.
Mishkin, Eric M. & G. A. Cabral. (1987). Inhibition of Cell-Associated Herpes Simplex Virus Type 2 Glycoproteins by  9-Tetrahydrocannabinol. Experimental Biology and Medicine. 185(1). 41–48. 6 indexed citations
16.
Cabral, G. A., Peter J. McNerney, & Eric M. Mishkin. (1987). Effect of micromolar concentrations of delta—9—tetrahydrocannabinol on herpes simplex virus type 2 replication in vitro. Journal of Toxicology and Environmental Health. 21(3). 277–293. 8 indexed citations
17.
Cabral, G. A., et al.. (1986).  9-Tetrahydrocannabinol Decreases Alpha/Beta Interferon Response to Herpes Simplex Virus Type 2 in the B6C3F1 Mouse. Experimental Biology and Medicine. 181(2). 305–311. 55 indexed citations
18.
Cabral, G. A., Eric M. Mishkin, Francine Marciano‐Cabral, et al.. (1986). Effect of  9-Tetrahydrocannabinol on Herpes Simplex Virus Type 2 Vaginal Infection in the Guinea Pig. Experimental Biology and Medicine. 182(2). 181–186. 42 indexed citations
19.
Cabral, G. A., Peter J. McNerney, & Eric M. Mishkin. (1986). Delta-9-Tetrahydrocannabinol Enhances Release of Herpes Simplex Virus Type 2. Journal of General Virology. 67(9). 2017–2022. 10 indexed citations
20.
Mishkin, Eric M. & G. A. Cabral. (1985). Delta-9-Tetrahydrocannabinol Decreases Host Resistance to Herpes Simplex Virus Type 2 Vaginal Infection in the B6C3F1 Mouse. Journal of General Virology. 66(12). 2539–2549. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald Lancz Breakdown of academic impact, for papers by S. Specter Breakdown of academic impact, for papers by Raymond Widen Breakdown of academic impact, for papers by O Gubbay Breakdown of academic impact, for papers by W. Ponti Breakdown of academic impact, for papers by Adam T. Hagymasi Breakdown of academic impact, for papers by Ken Williams Breakdown of academic impact, for papers by Dazhuang Shang Breakdown of academic impact, for papers by Yuan‐Chuan Chen Breakdown of academic impact, for papers by Amy C. Herring
Rankless by CCL
2026